SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000792977-20-000033
Filing Date
2020-04-28
Accepted
2020-04-28 07:34:20
Documents
17
Period of Report
2020-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amag8-k42820.htm   iXBRL 8-K 50820
2 EXHIBIT 10.1 amagexhibit101-42820.htm EX-10.1 89361
3 EXHIBIT 99.1 amagexhibit991-42820.htm EX-99.1 17026
9 amag_rgb.jpg GRAPHIC 151973
  Complete submission text file 0000792977-20-000033.txt   672280

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20200428.xsd EX-101.SCH 4450
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20200428_cal.xml EX-101.CAL 624
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20200428_def.xml EX-101.DEF 1474
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20200428_lab.xml EX-101.LAB 26142
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20200428_pre.xml EX-101.PRE 13580
13 EXTRACTED XBRL INSTANCE DOCUMENT amag8-k42820_htm.xml XML 4336
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 20822329
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences